Abstract
Purpose: Thyroid hormones enhance the metabolic rate and antioxidant metabolism by increasing the specific mitochondreal enzymes. It has been shown that due to the oxidative stress, components of the antioxidant system in erythrocytes increased in untreated toxic multinodular goitre patients and return to normal levels by using antithyroid drugs. However, it has not been shown that how L-thyroxine replacement therapy after total thyroidectomy effects these changes. Our aim was to compare the antioxidant levels in toxic multinodular goitre patients just before and 3-months after total thyroidectomy. Methods: Erythrocyte, plasma, and serum antioxidant activities (glucose-6-phosphate dehydrogenase, catalase, superoxide dismutase, nitric oxide, glutathione reductase, glutathione peroxidase, ceruloplasmin, malonyldialdehyde, vitamin E and vitamin C) were studied in 13 toxic multinodular goitre patients just before and 3 months after surgery. All the patients were euthyroid when the blood samples were collected. Euthyroidism was sustained with antithyroid drugs before operation and with L-thyroxine replacement therapy after total thyroidectomy. Statistical significance was assessed by Mann-Whitney U-test. Results: The findings showed that there is no significant difference between the erythrocyte, serum and plasma antioxidant enzyme activities, ceruloplasmin, serum tocopherol and, plasma vitamin C levels when the patients were euthyroid either with antithyroid drugs just before surgery or with L-thyroxine replacement therapy 3 months after total thyroidectomy. Conclusions: L-thyroxine replacement therapy after total thyroidectomy in toxic multinodular goitre patients does not affect the erythrocyte, plasma, and serum antioxidant activities, serum tocopherol and plasma vitamin C levels.
Keywords:
Antioxidants, hyperthyroidism, toxic multinodular goitre, thyroidectomy
References
1
Dumitriu L, Bartoc R, Ursu H, Purice M, Ionescu V. Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinology 1988; 26: 35–38.
2
Videla LA, Sir T, Wolff C. Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment. Free Radic Res Commun 1988; 5: 1–10.
3
Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology 1991; 121: 2112–2118.
4
Pereira B, Costa Rosa LBP, Safi DA, Becdhara EJH, Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 1994; 140: 73–77.
5
Asayama K, Kato K. Oxidative muscular injury and its relevance to hyperthyroidism. Free Radic Biol Med 1990; 8: 293–303.
6
Swaroop A, Ramasarma T. Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Biochem J 1985; 226: 403–408.
7
Paller MS. Hypothyroidism protects against free radical damage in ischemic acute renal failure. Kidney Int 1986; 29: 1162–1166.
8
Arumanayagam M, Swaminathan R. Ouabain-binding sites of reticulocytes from guinea pigs treated with triiodothyronine. Metabolism 1991; 40: 471–473.
9
Arumanayagam M, Swaminathan R. Induction of the ATPdependent proteolytic system in guinea pig reticulocyte lysates by triiodothyronine. Life Sci 1991; 49: 1369–1376.
10
Seven A, Seymen O, Hatemi S, Hatemi H, Yigit G, Candan G. Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation. Clin Chim Acta 1996; 256: 65–74.
11
DiGuiseppi J, Fridovich I. The toxicity of molecular oxygen. Crit Rev Toxicol 1984; 12: 315–342.
12
Pearson HA, Druyan R. Erythrocyte glucose-6-phosphate dehydrogenase activity related to thyroid activity. J Lab Clin Med 1961; 57: 343–349.
13
Swaminathan R, Segal NH, Chapman C, Morgan DB. Red-blood-cell composition in thyroid disease. Lancet 1976; 25: 1382–1385.
14
Nehal M, Baquer NZ. Changes in hexokinase and glucose-6-phosphate dehydrogenase in red cells during hypo and hyperthyroidism. Biochem Int 1989; 19: 193–199.
15
Kurasaki M, Saito T, Kaji H, Kojima Y, Saito K. Increased erythrocyte catalase activity in patients with hyperthyroidism. Horm Metab Res 1986; 18: 56–59.
16
Saito T. Superoxide dismutase level in human erythrocytes and its clinical application to the patients with cancers and thyroidal dysfunctions. Hokkaido Igaku Zasshi 1987; 62: 257–268.
17
Erkılıc AB, Alıcıguzel Y, Erkılıc M, Aksu A. Ceruloplasmin and vitamin E levels in toxic multinodular goiter. Nutr Res 1996; 6: 185–189.
18
Morini P, Casalino E, Sblano C, Landriscina C. The response of rat liver lipid peroxidation, antioxidant enzyme activities and glutathione concentration to the thyroid hormone. Int J Biochem 1991; 23: 1025–1030.
19
Abalovich M, Llesuy S, Gutierrez S, Repetto M. Peripheral parameters of oxidative stress in Graves'disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol 2003; 59: 321–327.
20
Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
21
Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem 1988, 34: 497-500.
22
Goldberg DM, Spooner RJ. Gluthatione reductase. In: Bergmeyer HU, ed. Methods in Enzymology. Chemie, 1983: 258-265.
23
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erytrocyte gluthation peroxidase. J Lab Clin Med 1967; 70: 158-169.
24
Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
25
Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated- oxygen toxicity in blood. Am J Obstet Gynecol 1979; 135: 372-376.
26
Ruperez FJ, Mach M, Barbas C. Direct liquid chromatography method for retinol, alpha- and gamma-tocopherols in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 800: 225-230.
27
Liu TZ, Chin N, Kiser MD, Bigler WN. Specific spectrophotometry of ascorbic acid in serum or plasma by use ascorbate oxidase Clin Chem 1982; 28: 2225-2228.28. Sunderman FW Jr, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970; 16: 903-910.
28
Fernandez V, Barrientos X, Kipreos K, Valenzuela A, Videla LA. Superoxide radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 1985; 117: 496-501.
29
Fernandez V, Llesuy S, Solari L, Kipreos K, Videla LA, Boveris A. Chemiluminescent and respiratory responses related to thyroid hormone- induced liver oxidative stress. Free Radic Res Commun 1988; 5: 77-84.
30
Mano T, Sinohara R, Sawai Y, Oda N, Nishida Y, Mokuno T, et al. Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle. J Endocrinol 1995; 145: 131-136.
31
Adamo A, Llesuy S, Pasquini J, Boveris A. Brain chemiluminiscence and oxidative stress in hyperthyroid rats. Biochem J 1989; 263: 273–277.
32
Videla LA, Correa L, Rivera M, Sir T. Zymosan-induced luminol-amplified chemiluminiscence of whole blood phagocytes in experimental and human hyperthyroidism. Free Radic Biol Med 1993; 14: 669–675.
33
Wilson R, Chopra M, Bradley H, McKillop JH, Smith WE, Thomson JA. Free radicals and Graves'disease: the effects of therapy. Clin Endocrinol 1989; 30: 429–433.
34
Lissi EA, Salim-Hanna M, Sir T, Videla LA. Is spontaneus urinary visible chemiluminiscence a reflection of in vivo oxidative stress? Free Radic Biol Med 1992; 12: 317–322.
35
Bianchi G, Solaroli E, Zaccheroni V. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metabol Res 1999; 31: 620–624.
36
Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000; 300: 107–117.
37
Venditti P, Di Meo S, De Leo T. Effect of thyroid state on characteristics determining the susceptibility to oxidative stress of mitochondrial fractions from rat liver. Cell Physiol Biochem 1996; 6: 283–295.
38
Guemouri L, Artur Y, Herbeth B, Jeandel C, Cuny G, Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 37: 1932–1937.
39
Aliciguzel Y, Ozdem SN, Özdem SS, Karayalcin U, Siedlak S, Perry G, Smith MA. Erythrocyte, plasma, and serum antioxidant activities in untreated toxic multinodular goiter patients. Free Radic Biol Med 2001; 30: 665-670.
40
Wefers H, Sies H. Oxidation of glutathione by the superoxide radical to the disulfide and the sulfonate yielding singlet oxygen. Eur J Biochem 1983; 137: 29–36.
41
Kurata M, Suzuki M, Agar NS. Antioxidant systems and erythrocyte life-span in mammals. Comp Biochem Physiol 1993; 106: 477–487.
42
Barnes G, Frieden E. Ceruloplasmin receptors of erythrocytes. Biochem Biophys Res Commun 1984; 25: 157–162.
43
Danis I, Marchiulenite D, Danite E, Cherniauskene R. Vitamin E and malondialdehyde in the blood serum of thyrotoxicosis patients. Rev Belge Med Dent 1990; 36: 21–24.
